Abstract:Background: Adverse drug reactions (ADRs), which are the phenotypic manifestations of clinical drug toxicity in humans, are a major concern in precision clinical medicine. A comprehensive evaluation of ADRs is helpful for unbiased supervision of marketed drugs and for discovering new drugs with high success rates. Objective: In current practice, drug safety evaluation is often oversimplified to the occurrence or nonoccurrence of ADRs. Given the limitations of current qualitative methods, there is an urgent need for a quantitative evaluation model to improve pharmacovigilance and the accurate assessment of drug safety. Methods: In this study, we developed a mathematical model, namely the Adverse Drug Reaction Classification System (ADReCS) severity-grading model, for the quantitative characterization of ADR severity, a crucial feature for evaluating the impact of ADRs on human health. The model was constructed by mining millions of real-world historical adverse drug event reports. A new parameter called Severity_score was introduced to measure the severity of ADRs, and upper and lower score boundaries were determined for 5 severity grades. Results: The ADReCS severity-grading model exhibited excellent consistency (99.22%) with the expert-grading system, the Common Terminology Criteria for Adverse Events. Hence, we graded the severity of 6277 standard ADRs for 129,407 drug-ADR pairs. Moreover, we calculated the occurrence rates of 6272 distinct ADRs for 127,763 drug-ADR pairs in large patient populations by mining real-world medication prescriptions. With the quantitative features, we demonstrated example applications in systematically elucidating ADR mechanisms and thereby discovered a list of drugs with improper dosages. Conclusions: In summary, this study represents the first comprehensive determination of both ADR severity grades and ADR frequencies. This endeavor establishes a strong foundation for future artificial intelligence applications in discovering new drugs with high efficacy and low toxicity. It also heralds a paradigm shift in clinical toxicity research, moving from qualitative description to quantitative evaluation.

Detecting Potential Adverse Drug Reactions Using Association Rules and Embedding Models.

Detecting Adverse Drug Event Signals from a Clinical CaseBase.

Prediction of adverse drug reactions based on knowledge graph embedding

Application of Association Rules Analysis in Mining Adverse Drug Reaction Signals

Identification of Adverse Drug Events in Chinese Clinical Narrative Text

Exploration of the Association Rules Mining Technique for the Signal Detection of Adverse Drug Events in Spontaneous Reporting Systems

Association Rules in the Surveillance of Adverse Drug Reaction Signals Detection

Detecting Potential Serious Adverse Drug Reactions Using Sequential Pattern Mining Method

Excavation of Multidimensional Association Rules in Adverse Drug Reaction and Construction of Warning Model

Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data

Research on Adverse Drug Reaction Prediction Model Combining Knowledge Graph Embedding and Deep Learning

Efficiently Mining Adverse Event Reporting System for Multiple Drug Interactions.

A Survey on Computational Approaches to Predicting Adverse Drug Reactions.

Discover Potential Adverse Drug Reactions Using The Skip-Gram Model

Graphic Mining of High-Order Drug Interactions and Their Directional Effects on Myopathy Using Electronic Medical Records

Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports

Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study

System and Empirical Study on Adverse Drug Reaction Warning Based on Association Rule

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms

Data Mining and Analytical Models to Predict and Identify Adverse Drug-drug Interactions

BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs